Table 6.
Spearman correlations between laboratory values and patient-reported outcomes in the group of treated patients
| Laboratory results - patient-reported outcomes | TSH | fT3 | fT4 | TPOAb | TgAb |
|---|---|---|---|---|---|
| ThyDQoL AWI-18 |
-0.231 |
-0.042 |
0.511** |
-0.191 |
0.072 |
| ThyDQoL Present QoLresent QoL |
-0.231 |
-0.282 |
0.301 |
-0.011 |
0.192 |
| ThySRQ number symptoms |
0.261 |
0.092 |
-0.311 |
0.151 |
-0.212 |
| ThyTSQ |
-0.171 |
-0.392 |
0.391 |
-0.021 |
0.052 |
| Short Form-36 physical |
-0.371 |
-0.072 |
0.211 |
-0.331 |
-0.041 |
| Short Form-36 mental |
0.162 |
-0.212 |
-0.082 |
0.272 |
0.202 |
| SCL-90-R |
0.051 |
0.022 |
-0.231 |
0.241 |
0.241 |
| WBQ-12 |
-0.151 |
0.051 |
0.361 |
-0.121 |
-0.031 |
| Hamilton Depression Scale Scale |
0.191 |
0.102 |
-0.401 |
0.431 |
0.271 |
| Beck Depression Inventory | -0.122 | -0.161 | -0.401 | 0.061 | 0.161 |
*p < 0.05, 1in the expected direction, 2against the expected direction. Abbreviations: WBQ – Well-Being Questionnaire, SCL – Symptom Check List, ThyDQoL – Thyroid-Dependent Quality of Life Questionnaire, ThySRQ – Underactive Thyroid Symptom Rating Questionnaire, ThyTSQ – Thyroid Treatment Satisfaction Questionnaire, AWI – Average Weighted Impact Score, QoL – Quality of Life, TSH – Thyroid Stimulating Hormone, fT3 – free Triiodothyronine, fT4 – free Thyroxine, TPOAb – Thyroid Peroxidase Antibodies, TgAb – Thyroglobulin Antibodies.